The investment seeks to maximize total return, through a combination of current income and capital appreciation... Show more
Category Miscellaneous
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BBC | 18.56 | 0.24 | +1.28% |
| Virtus LifeSci Biotech Clinical Trls ETF | |||
| CHI | 10.06 | 0.05 | +0.50% |
| Calamos Convertible Opportunities and Income Fund | |||
| USSE | 29.64 | 0.08 | +0.27% |
| Segall Bryant & Hamill Select Equity ETF | |||
| ARB | 28.18 | 0.01 | +0.05% |
| AltShares Merger Arbitrage ETF | |||
| VUSB | 49.78 | 0.02 | +0.04% |
| Vanguard Ultra-Short Bond ETF | |||
A.I.dvisor indicates that over the last year, SCFQX has been closely correlated with PADZX. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if SCFQX jumps, then PADZX could also see price increases.
| Ticker / NAME | Correlation To SCFQX | 1D Price Change % | ||
|---|---|---|---|---|
| SCFQX | 100% | N/A | ||
| PADZX - SCFQX | 80% Closely correlated | N/A | ||
| GIOSX - SCFQX | 60% Loosely correlated | N/A | ||
| MWCPX - SCFQX | 38% Loosely correlated | N/A | ||
| PMZNX - SCFQX | 23% Poorly correlated | N/A | ||
| BSIKX - SCFQX | 18% Poorly correlated | +0.10% | ||
More | ||||